The FDA has qualified AI-Based Histologic Measurement of NASH, or AIM-NASH — the first AI drug development tool — to assist ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only ...
Mount Sinai scientists developed V2P, a powerful new AI tool that predicts how specific DNA mutations translate into disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback